NuCana plc Gains 31.05%
Tue, Mar 03, 2020 at 05:30 PM
NuCana plc (NCNA:NASDAQ) rocketted at $7.85, representing a gain of 31.1%. On Mon 02 Mar 20, NCNA:NASDAQ hit a New 2-Week High of $5.99. The stock appeared on our News Catalysts scanner on Tue 25 Feb 20 at 06:01 PM in the 'EARNINGS' category. From Mon 10 Feb 20, the stock recorded 42.86% Up Days and 33.33% Green Days
The stock spiked on Mon 02 Mar 20 at $10.59 with a volume of 1M+.
About NuCana plc (NCNA:NASDAQ)
NuCana PLC is a clinical-stage biopharmaceutical company. It is focused on improving treatment outcomes for cancer patients by applying its ProTide technology.
Top 10 Gainers:
- Inovio Pharmaceuticals, Inc. (INO:NASDAQ), 69.7%
- Stealth BioTherapeutics Corp (MITO:NASDAQ), 61.58%
- Superconductor Technologies Inc. (SCON:NASDAQ), 59.19%
- Omeros Corporation (OMER:NASDAQ), 55.36%
- NCS Multistage Holdings, Inc. (NCSM:NASDAQ), 52.43%
- Glowpoint, Inc. (GLOW:NYSEMKT), 49.57%
- Zomedica Pharmaceuticals Corp. (ZOM:NYSEMKT), 34.15%
- Pacific Ethanol, Inc. (PEIX:NASDAQ), 31.65%
- NuCana plc (NCNA:NASDAQ), 31.05%
- Vislink Technologies, Inc. (VISL:NASDAQ), 30.81%